{"id":"W4313489278","doi":"10.1007/s00415-022-11517-w","title":"Efgartigimod improved health-related quality of life in generalized myasthenia gravis: results from a randomized, double-blind, placebo-controlled, phase 3 study (ADAPT)","year":2023,"lang":"en","type":"article","venue":"Journal of Neurology","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Myasthenia gravis; Medicine; Quality of life (healthcare); Placebo; Neurology; Visual analogue scale; Physical therapy; Neuroradiology; Clinical trial; Disease; Randomized controlled trial; Internal medicine; Pediatrics; Pathology; Alternative medicine; Psychiatry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.008780305,0.0003700225,0.004917719,0.0009463003,0.00007481339,0.00002119846,0.0003190701,0.0002600026,0.0000740679],"category_scores_gemma":[0.00241631,0.0002638968,0.0007841723,0.0007171308,0.0001704375,0.0001017116,0.0000896473,0.001088373,0.00001707292],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004301841,"about_ca_system_score_gemma":0.0005851164,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002433249,"about_ca_topic_score_gemma":0.000449306,"domain_scores_codex":[0.9894139,0.003192297,0.005692516,0.0004805414,0.0006524327,0.000568299],"domain_scores_gemma":[0.9932097,0.001781388,0.003620525,0.0005687291,0.0003587738,0.000460927],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9856064,0.002358044,0.001876736,0.00003238683,0.001026111,0.0006525054,0.002632037,0.0001859997,0.004539161,0.00009635715,0.0004932918,0.0005010057],"study_design_scores_gemma":[0.9823385,0.007124664,0.004829837,0.00005503003,0.0003336576,0.0001445213,0.0003159659,0.003711736,0.00005934488,0.0007755409,0.0001454036,0.0001658113],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.979233,0.0007205817,0.00003794084,0.01589954,0.0006582905,0.003287352,0.00004774638,0.00004447236,0.00007104404],"genre_scores_gemma":[0.9980815,0.0001654548,0.0001282438,0.001061414,0.0002658459,0.00007594263,0.00003473621,0.00004932277,0.0001375476],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01884846,"threshold_uncertainty_score":0.9999813,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07156943883593164,"score_gpt":0.3675229443199784,"score_spread":0.2959535054840468,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}